These results suggest that BET inhibitors indeed inhibit the expression of IDO1. Therefore, it was further examined where different BET inhibitors cause the corresponding changes in the mRNA levels of IDO1 in different tumor cells. This evidence concerns the gene DNER and neoplasm.